Datwyler recently announces the launch of its ready-for-sterilization (RFS) combiseals for cartridges that are used in injection devices such as pens and autoinjectors.
Washing and sterilization of rubber materials is more and more done by the rubber manufacturers.
These components take the burden off drug manufacturers to prep packaging components for sterilization, while helping to enhance the drug filling and packaging process.
RFS designed to reduce burden for drug manufacturers to prep packaging components for sterilization.
Pharmaceutical drug products are carefully engineered, manufactured, and administered with patient safety, drug efficacy, and business success in mind.
Geert Moens, Global Platform Leader Vial Closure Systems, Datwyler Healthcare, discusses recent technologies in the film and spray coatings market.
Datwyler’s Eugene Polini discusses what steps drug manufacturers can take to ensure that primary packaging systems remain sealed for product’s entire shelf life.
Contract Pharma reports how Datwyler is the first supplier to offer both film and spray fluoropolymer coating technologies for elastomeric closures for injectable drugs.
The demand for injectable drugs is rising. Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharma companies to examine the role – and risks – of their primary packaging.
Gabrielle Gehron, Scientific Support Manager at Datwyler, explains how to successfully analyze your pharma packaging needs and navigate through the packaging selection process.
Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of two years after steam sterilization.
Tom Lenaerts, Head of Global Process Engineering for Datwyler, speaks about smart manufacturing benefits in the pharma supply chain.
Gabrielle Gehron, Scientific Support Manager, Datwyler, explains how one can successfully analyse packaging needs and navigate through the packaging selection process
As prefilled syringes gain favor with healthcare providers, it’s time to look at how vaccine manufacturers can optimise designs to strengthen their parenteral packaging toolbox.
In an interview with the Swiss online portal moneycab, Datwyler CEO Dirk Lambrecht explains the acquisitions completed in 2022 and how this has increased Datwyler's diversification.
Datwyler Healthcare's Tabassam Sharif, regulatory affairs manager, and Eugene Polini, technical key account manager, explain how parenteral packaging suppliers are optimising their technologies and processes to meet regulatory requirements.
Digital technologies are reshaping healthcare, the pharmaceutical industry, and its supply chain. But what is the vision for the future, and how can companies along the value chain ensure they are ready?
The world wasn’t ready for COVID-19. But if we learn the right lessons, next time we’ll do better.
China has one of the fastest growing pharmaceutical markets in the world, which means a rising need for high-end packaging components naturally follows. To serve the demand and complete its global footprint, leading parenteral packaging component provider Datwyler recently announced its acquisition of Yantai Xinhui Packing, which includes a state-of-the-art production plant in Yantai, China.
Eugene Polini, Technical Key Account Manager at Datwyler examines the challenges drug developers are facing to speed up production lifecycles and what solutions are available to them.
Pharmaceutical Technology speaks to Katie Falcone, Scientific Support Manager at Datwyler, on important patient safety considerations in the world of parenteral packaging.
Datwyler’s Technical Key Account Manager, Eugene Polini, explains the drug development lifecycle and offers solutions for companies to better serve patient populations.
Pharmaceutical Technology spoke to Rahul Thakar, Technical Key Account Manager at Datwyler, to discuss his vision for a modernized supply chain, including five considerations on Industry 4.0 in the packaging component manufacturing arena.
Datwyler's Commercial Development Manager, Jeff Smythe, speaks with European Pharmaceutical Manufacturer about what we learned from the pandemic and how we're preparing for the future.
For an injectable medicine, a switch in presentation from vials to prefilled syringes is a prime example of a drug delivery change that significantly improves the efficacy and appeal of a drug product. Read Pharmaceutical Technology's interview with Datwyler expert Eugene Polini to learn about how parenteral packaging plays a role in drug life cycle management strategies.
The Environmental Impact Award is presented to the Alliance-to-Zero. Datwyler is shortlisted thanks to the multiple measures it has taken to reduce its environmental footprint.
Carina van Eester, Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges discusses key developments in pharmaceutical cartridges, including the next generation in aluminum seals and the wearable injectors of the future.
Alliance to Zero President Sebastian Gerner, Vice-President Robert O’Beirn and Committee Member Sabrina Gérard talk with ONdrugDelivery about the Alliance, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.
Beghini, managing director of the Datwyler healthcare plants and activities in Italy, talks about the five fundamental guidelines of his presidency programme: continuous training and learning, digital transformation, international spirit, technical development of Cerisie’s laboratories and maximization of recyclability of rubber scraps and waste.
Datwyler's Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler's NeoFlex™ plungers at the start of the COVID-19 pandemic.
Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. While most packaged drug products have specific requirements, newer sterilization techniques offer innovative ways of ensuring sterility that may be more suitable than standard sterilization processes. In this dedicated dialogue, the audience will learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.
Drug delivery devices are seeing rapid adoption in the injectable drug market due to the convenience and ease of administration for patients. Datwyler's Global Platform Leader for Prefilled Syringes and Cartridges, Carina Van Eester, discusses Datwyler's cartridge offerings designed with delivery device requirements in mind in the latest Special Injection Report with Drug Development & Delivery.
Pharmaceutical Technology spoke to Rahul Thakar, Technical Key Account Manager at Datwyler, to discuss his vision for a modernized supply chain, including five considerations on Industry 4.0 in the packaging component manufacturing arena.
As the storm from the COVID-19 pandemic begins to calm, it’s now time to reflect on what the pharmaceutical industry can learn from these challenges. This is exactly what leading parenteral packaging provider Datwyler did over a webinar on pandemic preparedness and primary packaging components earlier this year.
In the world of manufacturing parenteral drugs, high quality goes hand in hand with a product’s efficacy and the patient’s safety. Quality control is no afterthought for manufacturers– it has to be at the heart of everything they do. The best ingredients, facilities and manufacturing processes must be deployed throughout, with the best packaging components literally sealing the deal.
Thilo Schmierer, business development manager for Datwyler, discusses the company's latest medical offering, SoftPulse™, and how its revolutionary materials could bring monitoring home.
For their July issue, Pharmaceutical Technology spoke to Rahul Thakar, Technical Key Account Manager at Datwyler, to discuss his vision for a modernized supply chain, including five considerations on Industry 4.0 in the packaging component manufacturing arena.
Making every component count toward an environmentally responsible supply chain. By Dirk Borghs, CEO of Datwyler Healthcare Solutions.
Datwyler’s Technical Key Account Manager, Eugene Polini, discusses the industry trend towards biologics and how to design parenteral packaging for these challenging molecules.
In an interview with the Swiss online portal moneycab, Datwyler CEO Dirk Lambrecht explains the importance of system-critical components and outlines what Datwyler produces for suppliers of Covid 19 vaccines.
Yang Congri, Director of Market Development in China for Datwyler's Medical Business, discusses the future of parenteral packaging.
New technologies enable treatment tailored to each patient’s unique impairment profile.
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how Datwyler’s highest quality standard, FirstLine®, helps pharmaceutical companies minimize defects.
Datwyler discusses five considerations for selecting parenteral packaging for biologics.
Forecasts on the effects of climate change have prompted all industries, including the pharmaceutical sector, to implement more environmentally responsible practices.
Datwyler’s Vice President, Medical, Stefan Sevens, discusses five considerations for electrode design to maximize performance, comfort, and durability of wearables.
Datwyler is able to make an important contribution to the global fight against the pandemic with its system-critical elastomer components. The company is supporting the leading pharmaceutical companies in the provision of COVID-19 vaccines.
Stefan Sevens, VP Medical at Datwyler, talks about maximizing performance, comfort, and durability of wearable devices.
In an interview with the Swiss online portal «The Market», Datwyler CEO Dirk Lambrecht explains the potential of Healthcare Solutions and Food & Beverage, and explains why e-cars are not a disadvantage for Datwyler.
Datwyler's Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, shares key learnings since the launch of Datwyler's NeoFlex™ plungers at the start of the COVID-19 pandemic.
Datwyler’s Global Head of Marketing and Product Management, Massimo Mainetti, discusses how packaging suppliers are helping to reach global herd immunity in 3 years.
Focus on system-critical elastomer components for attractive global markets generates added value.
In times of crisis—like the current COVID-19 pandemic—there is no time or resource to waste on the issues that stem from defective or problematic drug packaging. Datwyler’s Key Account Manager, Rahul Thakar, explains how quality-by-design thinking enables drug efficacy and minimized opportunities for contamination.
Datwyler’s Senior Vice President, Pharma, Glenn Thorpe, discusses the future of parenteral packaging.
Datwyler’s Senior Vice President, Pharma, Glenn Thorpe, looks to the next-generation of parenteral packaging and how the latest innovations improve patient safety.
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how ‘Quality-by-design’ enables drug efficacy & minimises contamination.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Navigating pharma’s packaging challenges amid a pandemic.
Datwyler discusses five considerations for drug manufacturers to consider when selecting parenteral packaging for their drug products.
Datwyler’s Senior Vice President of Pharma, Glenn Thorpe, discusses the evolution of the parenteral drug market and how parenteral packaging is meeting these ever-changing challenges.
Glenn Thorpe, Senior Vice President, Pharma at Datwyler, says pharmaceutical companies should engage with packaging suppliers that can meet the industry demands of the pandemic.
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
In Korean publication, Plastic Net, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.
In Korean Packaging Association, Datwyler’s Global Product Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the features and benefits of Datwyler’s NeoFlex™ plungers.
In May, Project Jumpstart, a public-private initiative, was announced that will pump $138 million into the production of 100 million prefilled syringes by the end of this year and another 500 million in 2021, should a COVID-19 vaccine become available. Yet, industry gurus do not necessarily agree that the pandemic will have a positive impact on the injection delivery market. Datwyler’s Global Platform Leader for Prefilled Syringes and Cartridges, Carina van Eester, discusses the important role that coated plungers play in ensuring the appropriate functionality and compatibility of injection devices.
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
Carina Van Eester explores the benefits of fully coated plungers for prefilled syringes and cartridges.
Plunger Designed with Functionality in Mind.
The growth of injectables, personalized medicine, anti-counterfeiting measures, and automation are a few trends that may follow the industry into a new normal.
Rahul Thakar, PhD, technical key account manager at Datwyler Pharma, discusses the rise of injectables, quality control measures, and personalization.
Datwyler has launched its NeoFlex plungers to help developers better protect the integrity of injectable formulations and optimise the functionality of prefilled syringes and cartridge.
Container closure integrity (CCI) is an increasingly relevant issue in the pharmaceutical packaging industry. It addresses the maintenance of integrity to prevent microbial ingress in sterile product packaging until the time of use, as well as to restrict the loss of product contents and to prevent the entry of detrimental gases or other materials.
With the advent of biologics and highly sensitive drugs, primary packaging materials must meet the highest-level of functional, regulatory and cleanliness standards to ensure compatibility and ultimately, patient safety. Rahul Thakar, PhD, discusses Datwyler's solution to these ever-stricter requirements is their highest-quality manufacturing standard, FristLine™.
